מצגת שניה 18.3 ושיעור שני.pdf

Embed Size (px)

Citation preview

  • 7/28/2019 pdf. 18.3

    1/65

    Pharmacokinetics 2:

    IV Bolus Injection inOne CompartmentModel

    Book Chapter 3

    1

  • 7/28/2019 pdf. 18.3

    2/65

    Lecture Outline

    Model description Apparent volume of distribution Elimination half-life Elimination rate constant Plotting plasma levels Monitoring urinal excretion

    - amount remaining to be excretedmethod- rate of excretion method

    2

  • 7/28/2019 pdf. 18.3

    3/65

    The Scheme of IV Bolus

    1 compartment

    3

    This is the

    simplestform of the model:

    Distribution isimmediate

    No metabolism 100% excretedunchanged inurine

    .

  • 7/28/2019 pdf. 18.3

    4/65

    The General Equations of the Model

    4

  • 7/28/2019 pdf. 18.3

    5/65

    Mass vs. Concentration

    5

    And therefore

    Is the same as

    And also

  • 7/28/2019 pdf. 18.3

    6/65

    Mass vs. Concentration Mass Graphs

    6

  • 7/28/2019 pdf. 18.3

    7/65

    Mass vs. Concentration Concentration

    Graphs

    7

  • 7/28/2019 pdf. 18.3

    8/65

    Mass vs. Concentration

    8

    What is the difference between the two methods inpractice?

    .

    .

    Which one is more practical and important? -

    - .

  • 7/28/2019 pdf. 18.3

    9/65

    Application of the Model

    9

    Now that we have introduced the theoretical model,we will learn to apply it to find the following:

    Apparent volume of distribution ( V or V d ) The elimination half-life ( t ) The elimination rate constant ( K or K el ) The systemic clearance ( Cl )

    s

  • 7/28/2019 pdf. 18.3

    10/65

    Apparent Volume of Distribution

    105-6

  • 7/28/2019 pdf. 18.3

    11/65

    Apparent Volume of Distribution

    11

  • 7/28/2019 pdf. 18.3

    12/65

    Apparent Volume of Distribution

    12

    If we know the amount (=mass; = g, mg or g) of Iodine weput in the baker and measure the concentration of Iodinein the water (analogous to plasma or serum), we cancalculate the volume of the beaker irrespectively of itsactual volume.

    According to the calculation, beaker B will have largervolume

    ?

    . , , .

  • 7/28/2019 pdf. 18.3

    13/65

    Apparent Volume of Distribution - Calculation

    13

    To calculate the volume of distribution, we need toknow the drug dose X 0 (mass) and the initial drugconcentration in the plasma (C

    p )

    0(mass/volume)

    Then, (C p )0 = X 0 /V d V d = X 0 / (C p )0 Because actual (C p )0 cannot be measured, and wecant measure Xt either, we use the extrapolation of the C p vs. t graph

  • 7/28/2019 pdf. 18.3

    14/65

    Actual Factors That Determine the V d

    14

    The volume of distribution is determined by the physico-chemical properties of the drug

    The most important factor is the lipophilicity of the drug: themore lipophilic, the larger the V d

    Also important is the membrane permeability of the drug (oftenrelated to lipophilicity)

    Many drugs are highly bound to plasma proteins, or are toopolar to penetrate from blood to tissues and therefore have verylow Vd these include many acidic drugs like salycilates,sulfonamides and penicillins

    Theoretically, V d can vary between 3.5 and 500L. Actual V d svary between 7-10L to 200L

    .

    .

  • 7/28/2019 pdf. 18.3

    15/65

    The Nature of V d

    15

    Vd is a parameter, which means that for one drug andone individual it is a constant

    It is thus independent of dose and time in all cases

    It is similar, but not identical between persons It may vary with age and gender you can use apooled population average in some cases

    Vd for a drug in populations is often expressed asV/body mass in order to eliminate weight differencesbetween individual

  • 7/28/2019 pdf. 18.3

    16/65

    The Nature of V d

    16

  • 7/28/2019 pdf. 18.3

    17/65

    Elimination Half life

    175-6

  • 7/28/2019 pdf. 18.3

    18/65

    Elimination Half Life - Definition

    18

    The elimination half life t is the time when (C p)0 (and X0) is reduced by half

    t , like Vd is a parameter it varies between drugs

    and individuals, but is the same with time and dose .

    [] .

  • 7/28/2019 pdf. 18.3

    19/65

    Calculation of t

    19

    So, when t= t

  • 7/28/2019 pdf. 18.3

    20/65

    Calculation of t

    20

    Notice that we can calculate t with equation only if we know the elimination rate constant

    We can calculate both graphically from the semi-logconcentration vs. time graph

    In such a graph, you can use any two concentrationswhere one is half of the other instead of (C p )0 and0.5 (C p )0

    2 .

  • 7/28/2019 pdf. 18.3

    21/65

    Calculation of t

    21

  • 7/28/2019 pdf. 18.3

    22/65

    Examples of t

    22

  • 7/28/2019 pdf. 18.3

    23/65

    The Elimination Rate Constant

    23

  • 7/28/2019 pdf. 18.3

    24/65

    The Elimination Rate Constant

    24

    The elimination rate constant K or K el can becalculated using several related methods

    1. From the equation:

  • 7/28/2019 pdf. 18.3

    25/65

    The Elimination Rate Constant

    25

    2. Directly from the slope of the graph:-K = (slope) x 2.303, so

    Where Y represents C p

    and K = - (slope) x 2.3033. From t , because we know that:t = 0.693 /K K = 0.693/ t

  • 7/28/2019 pdf. 18.3

    26/65

    The Elimination Rate Constant

    26

    3. From t , because we know that:t = 0.693 /K K = 0.693/ t

    The unit of K is reciprocal time: time -1 in minutes orhours

    K represents the total elimination (irreversible loss) of drug from the body

    Therefore, it is composed of the rate constant forelimination of unchanged drug via the urine (K u) andmetabolism (K m), so that:

    K = K u + K m , or for two metabolites: K = K u + K m1 + K m2

  • 7/28/2019 pdf. 18.3

    27/65

    Plotting Plasma levels

    27

  • 7/28/2019 pdf. 18.3

    28/65

    Example of plotting C p vs. time

    28

  • 7/28/2019 pdf. 18.3

    29/65

    Example of plotting C p vs. time

    29

  • 7/28/2019 pdf. 18.3

    30/65

    Example of plotting C p vs. time

    30

    From the semi-log graph we first determine (C p )0 bydrawing the line from our first sample point at 1h to t =0

    (C p )0 = 63 g/mL

    Then, we determine t graphically using convenientconcentrations: 20, 10 and 5 g/mL t = 1.3h

    We can now calculate V d :and X0 a= 600mg and (C p )0 = 63 g/mLso

  • 7/28/2019 pdf. 18.3

    31/65

    Example of plotting C p vs. time

    31

    Now we can calculatethe overall eliminationrate constant from t:

    K = 0.693/ t = 0.693/1.3h= 0.533h -1

    or, from the slope of thegraph:

  • 7/28/2019 pdf. 18.3

    32/65

    How we will calculate in our exercise

    32

    The use of log-paper and graphical methods for findingslopes and other values are outdated

    Therefore, we will use Microsoft Excel and a different

    method of calculating K , t When we get a set of values of plasma levels vs. timepoints, we first convert the values to log, then put themin a graph of log(C

    p) against time

    Because we expect a straight line, we can use linearregression to find the best trend line ( )

  • 7/28/2019 pdf. 18.3

    33/65

    How we will calculate in our exercise

    33

    Time (h) C p(g/dL) log(Cp)

    0.5 211 2.32

    1.0 189 2.28

    1.5 163 2.21

    2.0 141 2.152.5 111 2.05

    3.0 97 1.99

    4.0 78 1.89

    5.0 62 1.797.0 39 1.59

    10.0 18 1.26

    15.0 6 0.78

    24.0 0.7 -0.15

  • 7/28/2019 pdf. 18.3

    34/65

    How we will calculate in our exercise

    34

    y = -0.1048x + 2.3384R = 0.9983

    -0.5

    0.0

    0.5

    1.0

    1.5

    2.0

    2.5

    0 5 10 15 20 25 30

    L o g

    [ X ] ( g

    / d L

    )

    time (h)

    Plasma Levels of Drug X

    Now we can use the trend line equation to determineour pharmacokinetic parameters

  • 7/28/2019 pdf. 18.3

    35/65

    How we will calculate in our exercise

    35

    The trend line equation is

    where -0.1048 represents the slope, and 2.338 the

    y-axis intercept Now

    And

    xC y p 10483384.2)log(

    1241.0303.21048.0303.2303.2

    h slope K K

    slope

    h

    h K

    t 88.2

    241.0

    693.0693.01

    21

  • 7/28/2019 pdf. 18.3

    36/65

    How we will calculate in our exercise

    36

    If we also know the dose ( X 0), we can now calculatethe apparent volume of distribution V from X 0 and ( C p )0

    We know that the Y-axis intercept represents (C p )0 , but

    we have to remember that our line-equation is log( C p ) and therefore, we have to convert our intercept back to(C p )0

    Given the dose was 100mg, then the apparent volumeof distribution is:

    dL g Y antiC ercept p /0.21810)log()(3384.2

    int0

    L

    Lmg

    mg

    dL g

    mg

    C

    X V

    V

    X C

    p

    d

    d

    p 9.45

    /18.2

    100

    /0.218

    100

    )(

    )(0

    000

  • 7/28/2019 pdf. 18.3

    37/65

    Performing an IV Bolus Experiment

    37

    When performing a real experiment:1. We administer a known dose of drug in a suitable vehicle(concentration x volume = dose) 2. Collect blood samples at least up to t x 4.32, more often at

    the beginning 4.32 3. Clean and analyze the samples with a suitable analytical

    method (most commonly bioassay with HPLC ) anddetermine C p at each time-point

    4. Plot the data in a semilogarithmic plot

    5. Calculate our PK parameters: V d , K el , t and (C p )0

  • 7/28/2019 pdf. 18.3

    38/65

    Performing an IV Bolus Experiment

    38

    Why using t x 4.32 ?

    4.32 5%

    Because t x 4.32 = t 5%

  • 7/28/2019 pdf. 18.3

    39/65

    Monitoring the Urine After IV Bolus

    39

  • 7/28/2019 pdf. 18.3

    40/65

    Why Should We Do It?

    40

    Monitoring the urine for unchanged drug andmetabolites is a way to investigate drug metabolism

    It is an easy and non-invasive method obtain PK data

    It has the obvious disadvantages that we can not samplevery often, and we can not determine the exact sampletime

    The data obtained reflects average excretion of aninterval

  • 7/28/2019 pdf. 18.3

    41/65

    Cumulative Excretion in Urine Graph

    41

  • 7/28/2019 pdf. 18.3

    42/65

    Cumulative Excretion in Urine

    42

    First of all, we can determine if there is a drugmetabolism: if (X u ) X 0, there is metabolism,and K Ku

    , . If the metabolite is excreted in urine (which is almost

    always the case), then the mass balance dictates:where: (X) t is the amount of drug in the body at time t,(Xu) is the amount excreted in the urine, (X m) is theamount of metabolite in the body, and (X mu ) is themetabolite excreted in the urine

  • 7/28/2019 pdf. 18.3

    43/65

    Cumulative Excretion in Urine

    43

  • 7/28/2019 pdf. 18.3

    44/65

    How Urinary Excretion Data are used

    44

    There are two methods we can use to calculateparameters from urinary excretion data:1. The method based on the Amount Remaining to be

    Excreted, called the ARE, or the Sigma Minus method 2. The Rate of Excretion Method

  • 7/28/2019 pdf. 18.3

    45/65

    Amount Remaining To BeExcreted (ARE) Method

    45

  • 7/28/2019 pdf. 18.3

    46/65

    The ARE method

    465-4

    In this method, we use the fact that the amount of drugremaining in the body is equal to the dose minus theexcreted amount to make an elimination plot and

    calculate the elimination constant. So all the drug isexcreted in urine:

  • 7/28/2019 pdf. 18.3

    47/65

    The ARE method

    47

    We can describe the amount remaining in the body by

    where (X u ) - (X u )t is the amount remaining in the body and (X u ) = X 0 the given dose Now we can calculate the excretion rate constant from the graphof the remaining amount vs. time

  • 7/28/2019 pdf. 18.3

    48/65

    The ARE method

    48

    5:00

  • 7/28/2019 pdf. 18.3

    49/65

    The ARE method Limitations

    495-4

    The ARE method is difficult to apply because:1. Urine must be collected until there is almost no drug

    in urine because we need to know that (X u) X0

    We need about 7t - this can be very long time7

    , !!! .

    2. We need to collect all the urine in all samples3. There is a cumulative build up of errorThe ARE method is thus not very precise and very timeconsuming method especially for drugs with long t

    , ARE

    ,

  • 7/28/2019 pdf. 18.3

    50/65

    ARE When Drug Metabolism Occurs

    50

    When there is drug metabolism, then (X u) X0 andKu K

    Using Laplace transform to integrate, weget

    This equation allows for predicting the amount excretedat time t the if elimination rate constant K and excretionrate K

    u are known

    _XK

    KU

  • 7/28/2019 pdf. 18.3

    51/65

    ARE When Drug Metabolism Occurs

    51

    When t = , the exponential term progresses to 0

    and the equation becomes

  • 7/28/2019 pdf. 18.3

    52/65

    ARE When Drug Metabolism Occurs

    52

    If we substitute (K uX0)/K with (Xu) in

    we get:

  • 7/28/2019 pdf. 18.3

    53/65

    ARE When Drug Metabolism Occurs

    53

    Now, we transform

    into logarithmic equation

    where the term on the left represents the amountremained to be excreted

  • 7/28/2019 pdf. 18.3

    54/65

    ARE When Drug Metabolism Occurs

    54

    From the equation, we can draw the graph, calculate Kand extrapolate to find (X u) even if we dont know if there is metabolism

    Notice thesimilarity to C p calculations

  • 7/28/2019 pdf. 18.3

    55/65

    Rate of Excretion (ROE) Method

    55

  • 7/28/2019 pdf. 18.3

    56/65

    ROE Method: No Metabolism

    56

    We have already seen thatand that

    if Ku= K

    Now, we substitute the X from the differential equation,we get

  • 7/28/2019 pdf. 18.3

    57/65

    ROE Method: No Metabolism

    57

    However, in practice we measure and average rate overthe period of urine collection.

    Therefore, we express the equation as:

    where we take the average time (t 2+t 1 )/2 to mach theaverage time to the average rate

    .

  • 7/28/2019 pdf. 18.3

    58/65

    ROE Method: No Metabolism

    58

    The graphs show the rate of urinary excretion vs. the average timeover which the excretion was measured in linear scale (a) andsemilog scale (b). Notice that the intercept is not X 0, but KuX0

  • 7/28/2019 pdf. 18.3

    59/65

    ROE Method: No Metabolism

    59

    An example:

    Notice that you calculate the rate over the time interval,

    but you plot it against the average time measured from t 0 From the graphs of d Xu/ dt, we can calculate t , X 0 and K

    K

  • 7/28/2019 pdf. 18.3

    60/65

    ROE Method: With Metabolism

    60

    The fact that X 0 (Xu) has no consequences for thecalculation because we extrapolate to X 0 and not to (X u)

    Naturally, K u K

    We can use and if the drug is also

    monitored in the blood

    Notice that we have to know K and X 0

  • 7/28/2019 pdf. 18.3

    61/65

    ROE Method: With Metabolism

    61

    The logarithmic form

    can be used todetermine K u at the intercept of thegraph

  • 7/28/2019 pdf. 18.3

    62/65

    ROE Method

    62

    This method tends to overestimate the interceptbecause of the way the time average is calculated

    The error is proportional to the sample interval

    Comparison of K and K u can tell us if X is metabolized The table shows the

    overestimation of the

    intercept K u(X0) in %as function of theinterval betweensamples rel. to t

  • 7/28/2019 pdf. 18.3

    63/65

    AREvs. ROE Methods: an Example

    63

    A bolus injection of 80mg of drug U is administered The data and calculation are given in the table below forboth methods

  • 7/28/2019 pdf. 18.3

    64/65

    AREvs. REM Methods: an Example

    64 ARE ROE

    -----------------------------------=====================-

    ROE

  • 7/28/2019 pdf. 18.3

    65/65

    AREvs. REM Methods: an Example

    Both methods are useful In the ARE method, we have to collect samples for verylong time in order to avoid error in the estimation of X

    X In the ROE method, we have to take samples frequently inorder to avoid overestimation of the intercept K u(X0) andtherefore, overestimation of K u

    ..